TLX1 |
P31314
|
T cell leukemia homeobox 1
|
|
0.74 |
0.644 |
0.308 |
BCL7A |
Q4VC05
|
BAF chromatin remodeling complex subunit BCL7A
|
|
7.8E-02 |
0.736 |
0.385 |
IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
MLLT10 |
P55197
|
MLLT10 histone lysine methyltransferase DOT1L cofactor
|
Transcription factor
|
1.00 |
0.551 |
0.462 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
SPOP |
O43791
|
speckle type BTB/POZ protein
|
|
1.00 |
0.597 |
0.500 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
FOXN3 |
O00409
|
forkhead box N3
|
|
0.93 |
0.686 |
0.538 |
PICALM |
Q13492
|
phosphatidylinositol binding clathrin assembly protein
|
Transporter
|
1.00 |
0.592 |
0.538 |
CD79B |
P40259
|
CD79b molecule
|
Receptor
|
0.92 |
0.576 |
0.577 |
CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
MAD2L1 |
Q13257
|
mitotic arrest deficient 2 like 1
|
|
9.3E-03 |
0.575 |
0.615 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
LMO2 |
P25791
|
LIM domain only 2
|
|
0.16 |
0.585 |
0.654 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
BTG1 |
P62324
|
BTG anti-proliferation factor 1
|
|
0.54 |
0.564 |
0.692 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
REL |
Q04864
|
REL proto-oncogene, NF-kB subunit
|
Transcription factor
|
1.00 |
0.579 |
0.692 |
BCL3 |
P20749
|
BCL3 transcription coactivator
|
|
0.99 |
0.541 |
0.731 |
PRDM1 |
O75626
|
PR/SET domain 1
|
|
0.96 |
0.538 |
0.731 |
CCNE1 |
P24864
|
cyclin E1
|
Enzyme modulator
|
0.97 |
0.538 |
0.731 |
CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |